
Sign up to save your podcasts
Or


Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Recorded on September 6, 2022
Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju provides an overview of BPDCN, including major updates in the treatment of the disease since our last episode on this topic in 2019. What is BPDCN? How is it treated? Is it curable? What resources are available for patients living with this rare disease? Join the conversation and learn more today!
This podcast episode is supported by Stemline Therapeutics, Inc.
By Blood Cancer United4.8
1212 ratings
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Recorded on September 6, 2022
Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju provides an overview of BPDCN, including major updates in the treatment of the disease since our last episode on this topic in 2019. What is BPDCN? How is it treated? Is it curable? What resources are available for patients living with this rare disease? Join the conversation and learn more today!
This podcast episode is supported by Stemline Therapeutics, Inc.

43,680 Listeners

317 Listeners

3,348 Listeners

56,692 Listeners

46 Listeners

1,148 Listeners

207 Listeners

187 Listeners

22 Listeners

52 Listeners

8 Listeners

20,517 Listeners

51 Listeners

44 Listeners

31 Listeners